BPC 157 may indirectly provide immune system support during physical stress or recovery
The exception: people coming from tirzepatide or semaglutide If you have been on semaglutide or tirzepatide and are transitioning to retatrutide, your body already has significant adaptation to GLP-1 and possibly GIP receptor activation
Chicago Pramanik, Priyanjana
The rationale for caution relates to redundancy: both drug classes ultimately increase GLP-1 signaling at the pancreatic beta cell
You should not use Wegovy if you or an immediate family member has ever had medullary thyroid carcinoma (MTC), or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Lifestyle Foundations Were Not Built During the Medication Phase GLP-1 medications make it easier to eat less, but they do not automatically preserve muscle, improve metabolic flexibility, or rebuild movement habits